Mesirow Financial Investment Management Equity Management purchased a new position in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 1,473,010 shares of the software maker’s stock, valued at approximately $18,797,000. Mesirow Financial Investment Management Equity Management owned 0.81% of Allscripts Healthcare Solutions as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of the company. Guggenheim Capital LLC raised its stake in shares of Allscripts Healthcare Solutions by 4.4% in the fourth quarter. Guggenheim Capital LLC now owns 149,708 shares of the software maker’s stock worth $1,529,000 after buying an additional 6,301 shares during the last quarter. Thrivent Financial for Lutherans raised its stake in shares of Allscripts Healthcare Solutions by 7.7% in the fourth quarter. Thrivent Financial for Lutherans now owns 31,450 shares of the software maker’s stock worth $321,000 after buying an additional 2,260 shares during the last quarter. Foundry Partners LLC raised its stake in shares of Allscripts Healthcare Solutions by 11.1% in the first quarter. Foundry Partners LLC now owns 29,418 shares of the software maker’s stock worth $373,000 after buying an additional 2,950 shares during the last quarter. Bank of Montreal Can raised its stake in shares of Allscripts Healthcare Solutions by 60.2% in the first quarter. Bank of Montreal Can now owns 9,914 shares of the software maker’s stock worth $126,000 after buying an additional 3,724 shares during the last quarter. Finally, Capstone Asset Management Co. raised its stake in shares of Allscripts Healthcare Solutions by 1.4% in the first quarter. Capstone Asset Management Co. now owns 16,977 shares of the software maker’s stock worth $215,000 after buying an additional 230 shares during the last quarter.

Allscripts Healthcare Solutions, Inc. (MDRX) opened at 13.25 on Tuesday. The firm has a 50-day moving average price of $12.46 and a 200-day moving average price of $12.12. Allscripts Healthcare Solutions, Inc. has a one year low of $9.80 and a one year high of $15.17. The firm’s market capitalization is $2.40 billion.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its earnings results on Thursday, August 3rd. The software maker reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.15 by $0.04. Allscripts Healthcare Solutions had a negative net margin of 11.54% and a positive return on equity of 5.97%. The company had revenue of $426.10 million during the quarter, compared to analysts’ expectations of $424.94 million. During the same quarter last year, the business posted $0.14 earnings per share. The company’s revenue for the quarter was up 10.2% compared to the same quarter last year. Equities analysts anticipate that Allscripts Healthcare Solutions, Inc. will post $0.62 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Mesirow Financial Investment Management Equity Management Invests $18.80 Million in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)” was published by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be accessed at https://www.dailypolitical.com/2017/08/08/mesirow-financial-investment-management-equity-management-invests-18-80-million-in-allscripts-healthcare-solutions-inc-nasdaqmdrx.html.

A number of equities research analysts have recently weighed in on MDRX shares. Zacks Investment Research upgraded Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research note on Wednesday, April 19th. Maxim Group restated a “buy” rating and set a $16.00 price target on shares of Allscripts Healthcare Solutions in a research note on Friday, May 5th. Bank of America Corporation initiated coverage on Allscripts Healthcare Solutions in a research report on Monday, May 15th. They issued a “neutral” rating and a $14.00 target price on the stock. Cantor Fitzgerald reiterated a “neutral” rating and issued a $13.00 target price on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. Finally, BidaskClub upgraded Allscripts Healthcare Solutions from a “strong sell” rating to a “sell” rating in a research report on Tuesday, June 13th. One analyst has rated the stock with a sell rating, ten have given a hold rating and nine have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $14.74.

In other Allscripts Healthcare Solutions news, President Richard J. Poulton sold 25,000 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Tuesday, May 16th. The stock was sold at an average price of $12.06, for a total value of $301,500.00. Following the transaction, the president now directly owns 412,488 shares in the company, valued at approximately $4,974,605.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.75% of the company’s stock.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.